Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Pharmacology > Pharmacokinetics > Flashcards

Pharmacokinetics Flashcards

1
Q

Oral administration of drugs

A

Must first pass through the gut epithelium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Absorption

A

A first-order process (i.e. the rate of is proportional to the amount of drug present at the site of absorption)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Cmax

A

Time at which absorption and elimination are equal to each other.
-max conc of the drug in the plasma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Tmax

A

The time where Cmax occurs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

IV bolus

A

Maximal plasma concentration is instantaneous (Co)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is oral bioavailability governed by?

A

Governed by solubility (GI lumen), permeability (GI epithelium), metabolism in the gut and liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is distribution from the plasma governed by?

A

Governed by membrane permeability, fenestration, blood flow. plasma protein binding and partitioning (into body fat)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Which organs have high fenestration? What does that mean?

A
  • Liver and kidney

- Means that the drug can pass very easily

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

If a person is sick, what can that do to the degree of fenestration?

A

It can change

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What has decreased blood flow?

A

adipose tissue, bone and synovia?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Why is it hard to treat a joint infection?

A

Because synovia has low blood flow, and it’s hard to get antibiotics into a tissue that’s not well perfused.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Fick’s Law (formula)

A

Flux (molecules per unit time) =

(C1-C2) x Area x Permeability/Thickness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Permeability (P)

A

proportional to lipophilicity/molecular weight

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Most drugs are

A

weak acids or weak bases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Accumulation

A

Eventually plateaus because it is in equilibrium with elimination [Css—concentration steady-state]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Bioavailability

A

Used to indicate the fraction (F) of an administered dose of drug that reaches the systemic circulation unchanged.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the bioavailability of a drug administered via IV?

A

100%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Volume of distribution (Vd)

A

Relates the amount of drug in the body to the concentration of drug in the plasma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Small Vd occurs when?

A

Lipid solubility is low, plasma protein binding occurs and there is a low level of tissue binding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

High Vd occurs when?

A

Lipid solubility is high, low plasma protein binding occurs and there is a high level of tissue binding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Rate of elimination of a drug

A

Is proportional to the amount of drug in the fluid characterized by the volume Vd
Rate of elim = k * A
units amt/time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Elimination Half-life, t1/2

A

The time when the original plasma concentration is 50% of initial dose.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Clearance (CL)

A

Is a factor that relates the rate of elimination of a drug to the concentration of the drug in plasma. Units are flow (such as 1 L/hr). vol/time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Dose/AUC

A

CL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Where is a drug that’s a weak acid be absorbed?

A

In the stomach

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What does AUC tell us

A

total exposure to the drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

If we want to know how much of a drug is bioavailable, what do we look at on a graph?

A

AUC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

(T/F) A drug distributes itself differently in different tissues?

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What is lipophilicity expressed by?

A

n octanol/H2O

aka (nol-p)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What happens to permeability if we incr MW at the same nol-p?

A

less permeable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

What happens to permeability if we increase nol-p at the same MW?

A

more permeable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

An acid is uncharged when it is?

A

protonated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

A base is uncharged when it is?

A

unprotonated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

What happens after a weak acid is protonated and crosses a membrane?

A

It gets ion trapped based on the pH and establishes a new equilibrium and can’t diffuse back

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Aspirin is strong acid, is more protonated in duodenum (pH 5) or plasma (pH 7.4)

A

in the duodenum (weaker base). Acid is more protonated in a more acidic environment.
this way it doesn’t want to be protonated to diffuse back into the duodenum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

What is steady state?

A
  • Accumulation and elimination are linear.
  • People reach this after using a drug for a while.
  • It’s a nice happy therapeutic range (Cp max and Cp min are consistent)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

What does a graph look like for multiple dosing of an IV bolus?

A

There are spikes because you give a dose it clears, give a dose, clears….

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Bioavailability eqn

A

F= [(AUC)oral / (AUC)iv] x [(Dose)iv / (Dose)oral]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Vd =

A

amount / Cp

40
Q

Vd for bolus IV injection

A
  • simplest case

- permits DIRECT calculation of initial conc of drug in plasma (Cp) for any given dose!

41
Q

Elimination is almost always

A

“first-order”

42
Q

What is a first order process?

A

rate of elimination of a drug is proportional to the amt of drug in the fluid characterized by Vd

43
Q

How to calculate Cp

and what can we use this eqn for?

A

Cp = Cp(initial) x e^(-kt)
-use to calculate where along this slope on the graph (time vs plasma drug conc) you are from the initial dose (with known constant and known time)

44
Q

First order rate constant (k)

A

-relates rate of elimination to the amount of drug
rate elimination = k * A
-uses reciprocal time units

45
Q

Rate of elimination in terms of clearance (eqn)

A

rate of elimination = CL * C

46
Q

Cp

A

plasma concentration

amount/vol

47
Q

Why is clearance important?

A
  • crucial for designing regimen for long term steady state drug administration.
  • basically make sure to give you as much drug as you will clear so you’re at stead state level. if given too much will reach toxic level
48
Q

Dosing rate =

A

dosing rate = rate of elimination = Cl * Css

49
Q

CL derived eqns because CL is the key to other pharmacokinetic parameters.

A

CL= k*Vd

CL=Dose/AUC

50
Q

CL practicalities

A
  • CL is hypothetical volume of fluid that is effectively and completely cleared of drug per unit time
  • The fluid containing the drug has apparent Vd
  • CL can be total body or single extractions (like renal CL or hepatic CL)
51
Q

Which clearance eqn is based on mass so doesn’t matter which model we use?

A

CL = Dose / AUC

52
Q

Complication of 1 compartment model ex

A

Thiomental after IV bolus

  • has different kinetics going to different places
  • not used for maitenence because it builds up in fat so after a while it will come out of fat and person feels woozy. It is instead used to induce anesthesia bc goes to brain and viscera very quickly.
53
Q

2 compartment model

A
  • you’re not a well mixed 10 L sac, there is some slower step here as the drug gets out of the plasma
  • a lot more mathematically complex
  • makes the parameters we derived earlier more complex.
54
Q

soft spots in drug development

A

spots in the chemical structure that human enzymes will immediately chew up so that (a) we will not keep delivering the way we think we are, and (b) we will not keep dosing the way we think we are.

55
Q

Inactivating drug bio-transformation. What is it and what does it do?

A

Biotransformation can turn drug from active to inactive.
Inactivation of compounds- changes in structure lead to loss of receptor binding.
-It limits the duration of drug action
-Protection against toxic chemicals

56
Q

Activating drug bio-transformation.

A

Biotransformation can turn drug from inactive to active

-For activation of pro-drugs – bc many drugs are not in their most active forms when we take them.

57
Q

Excreting drug bio-transformation

A
  • improves water solubility for easy excretion
  • so increase hydrophilicity
  • lower tissue distribution
  • increase renal and bile excretion
  • basically stick something on the drug that makes it more polar.
58
Q

Toxic bio-transmormation

A

Bioactivation of cytotoxins, mutagens and carcinogens.

Ex- benzo(a)pyrene on it’s own is fine but once metabolized turns into nasty carcinogen

59
Q

Most drugs can be metabolized by a single reaction (T/F)

A

False, multiple rxns

60
Q

First pass effect

A

after you take a drug orally, it’s that first ride across your liver and lungs get metab before it hits systemic circ

61
Q

Enterohepatic recycling. What is it, and for what type of drug will this happen to?

A

Drug goes from the liver into our bowels and then cycle back into liver and back to bowels.
-this will happen with drugs that aren’t polar enough (mildly lipophilic metabolite)

62
Q

Phase 1 bio-transformations

A
  • This is the “functionalization”
  • First step of introducing a new functionality on the drug.
  • Cyt p450 is the main one but there ARE others.
  • oxidations
63
Q

Synonyms for cytochrome p450

A
  • monooxygenase

- mixed function oxygenase

64
Q

How are cyps in animals, plants and bacteria

A
  • membrane associated in animals and plants

- soluble in bacteria

65
Q

Why is membrane association functionally useful?

A

Because we can do microsomal fractionation – can disrupt liver membranes and lower fraction be centrifuge, then we can use that fraction to perform metab on drugs and predict metab.

66
Q

Explain how CYP 3A4 is classified

why is this classification good?

A

3 - gene family
A- subfamily
4- enzyme identity
-good because helps predict what their substrates will be and what their function will be

67
Q

Catalysis of CYPs requires

A

-NADPH (high energy cofactor)
-molecular oxygen (O2)
energy intensive process so we need a living energy producing system to do this (you have to be breathing)

68
Q

p450 catalytic cycle

A
  • drug binds to cyp

- heme goes through reduction and oxidation– that is needed to bind to the drug to do it’s job

69
Q

What does cyt p450 reductase do?

A

transfers electrons from NADPH to the P450s during catalysis

70
Q

Typical cyt p450 reactions, what do most of them do?

A
  • aliphatic hydroxylation (add OH to CH chain)
  • S- N- oxidation (add O to S or N)
  • O-dealkylation (remove alkyl)
  • N-demethylation
  • Oxidative deamination (remove amine)
  • epoxidation (bad)- epoxide is unstable, reactive and binds to DNA
  • they basically increase polarity
71
Q

What kind of cyps to humans also contain?

which ones are important and which family is important?

A

58 CYP pseudogenes –these are not fully expressed. Only a small set are responsible for metab of drugs.

  • Important 1A2 and 2E1
  • 3A is important family
72
Q

Because of low specificity, a single drug can metabolized by _____ p450s
also, a single cyp _____

A

several

-also a cyp can catalyze different reactions on the same drug

73
Q

Indicibility of p450s and exs

A
  • they are controlled by a large variety of TFs
    -ex- 2E1 is induced by ethanol. If someone drinks a lot and then takes a tylenol, they will have a very different drug metabolism.
    ex- cyp2B is induced by phenobarbital
74
Q

Genetic variability of cyps

A
  • show polymorphic expression
  • cyps can be genetically variant across races and populations
  • cyps vary by copy number – how many cyps expressed per gene. Higher copy number variants are fast metabolizers.
75
Q

CYP34A

A

most abundant human cyp

76
Q

What family are most of the liver cyps?

A

3A

77
Q

What is CYP3A4 inhibited by

A

grapefruit juice and certain anti-fungals

78
Q

CYP1A2

A
  • impt in toxicology
  • inducible by polycyclic aromatic hycrocarbons found in cigarette smoke
  • inh by grapefruit juice
  • substrates are caffeine
79
Q

Phase II reactions

A
  • conjugations – take the prod of phase I and add something to it.
  • more likely to be inactive and MUCH more polar – allows them to get cleared.
  • require also high energy cofactors (PAPS)
80
Q

Glucuronic acid conjugation

A
  • most significant phase 2 rxn
  • co factor supply is readily available in liver
  • variety of functional groups used as substrates can be conjugated
  • glucuronic acid just replaces the hydrogen on the hydroxyl group (or amine, sulfhydryl)
81
Q

UDP-glucuronosyltransferase (UGT)

A
  • catalyzes glucaronic acid conjugation
  • it’s microsomal
  • present in liver but also in extra-hepatic tissue
  • inducible but less impt bc phase 1 rxn is limiting factor. there are enough phase 2 enzymes to deal with all plase 1
82
Q

Sulfation

A

conjugating group: SO3- (carrying charge so polar)

  • the cofactor is more important and sometimes
  • phase II rxn
  • activated form of SO3- is PAPs
  • saturable kinetics – the cofactor PAPs may be limiting
  • certain drugs cant be adequately sulfated if you take them long time or take multiple drugs cleared by this mech
  • significant for endogenous substrates (mostly steroids)– so high levels of certain drugs interfere with that pathway
83
Q

sulfotransferases

A

enzyme for sulfation

  • abbrev SULT
  • has multiple families (10 enzymes in 3 families)
84
Q

SULT1A1

A
  • type of SULT for sulfation

- also works on estrogens

85
Q

N-acetylation

A
  • exception*- wemake the phase 2 metabolite less polar instead of more polar
  • add acetyl group instead of taking it away
  • Acetyl coA cofactor
86
Q

N-acetylation typical reactions

A
  • aromatic primary or aliphatic amines
  • substituted hydrazine
  • aryl-substituted sulfonamide
87
Q

Integration of Phase 1 and phase II metabolism

A
  • for a given drug you have demethylation or dealkylation, then hydroxylation then conjugation
  • all of these happen at different ratios
  • Most drugs are metabolized by more than one pathways
88
Q

Factors affecting drug metabolism: age

A
  • newborns don’t have many metabolic enzymes
  • takeaway- be careful giving drugs to pregnant woman or newborn.
  • elderly- metabolism slows, bp changes
89
Q

Factors affecting drug metabolism: pathological and physiological states

A

-impairment of liver function really effects

90
Q

Factors affecting drug metabolism: drug-drug interaction

A
  • cyp induction
  • many affect phase I enzymes
  • one drug changes metab of another drug
  • toxicity (comp inh of drugs metab by the same enzyme)
  • unfortunate ex- seldane pro drug for allegra.
91
Q

Factors affecting drug metabolism: genetic

A
  • plolymorphism

- classified to EM (extensive metabolizers), (PM) poor metabolizers, ultrarapid metabolizers

92
Q

Polymorphism in drug metabolizing enzymes and exs of polymorphic human enzymes

A

-not a random mutation, its a DNA seq difference in more than 1% of pop
exs- CYP2D6, CYP2c19, NAT, Aldehyde dehydrogenase

93
Q

Determinants of pharmacokinetics

A

ADME; absorption, distribution, metabolism and excretion (elimination)

94
Q

Drug metabolism can be

A

inactivation of active drugs; activation of pro-drugs; increases in water solubility for easy excretion; bio-activation of cytotoxins, carcinogens etc.

95
Q

N-acetylation

A

Uses acetyl coenzyme A as a cofactor; products are less polar

Pharmacology (10 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions